Attgeno
1 known investors
Developer of Supernitro, a first-in-class nitric oxide delivery therapy for pulmonary hypertension prevention and treatment.
1 known investors
Developer of Supernitro, a first-in-class nitric oxide delivery therapy for pulmonary hypertension prevention and treatment.